Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival without ...

In a first-of-its-kind procedure, clinicians at the University of Maryland Medical Center in Baltimore removed a rare spinal tumor through a patient’s eye socket.  The patient, Karla Flores of ...

Lauren Smith, 30, from Stanway, has launched a fundraiser to access a potentially life-saving treatment in the United States.

Jack David was on his family’s annual trip to Priest Lake, Idaho, when he woke up in the middle of that vacation and felt a ...

In a first-of-its-kind surgery, a team led by a University of Maryland Medical Center (UMMC) neurosurgeon has successfully ...

First-line treatment with a Keytruda combo had an overall survival of 17.6 months in some with recurrent/metastatic head and ...

Neurosurgeons at the University of Maryland Medical Center in the U.S. have achieved a groundbreaking milestone by ...

Low-dose computed tomography is more sensitive than chest radiography in detecting lung metastases or second primary lung cancer in patients with HNSCC.

Karla Flores had a tumor strangling her spinal cord near the base of her skull. Doctors weighed whether they should attempt a ...

Adding pembrolizumab before and after surgery reduced recurrence and improved response in patients with locally advanced head ...

Reducing the dose of radiation to nodal regions is safe and does not impact the risk of recurrence in patients with head and neck cancer, a study suggests.

Ravindra Uppaluri, MD, PhD, discussed the KEYNOTE-689 trial, which investigated pembrolizumab in locally advanced head and ...